Tempo Australia Limited operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tempo Australia Limited with three other
companies in this sector in Australia:
sales of 17.64 million Australian Dollars [US$13.87 million]
of which 77%
was Bronchitol and Aridol),
Xrf Scientific Ltd
(21.54 million Australian Dollars [US$16.93 million]
of which 40%
was Precious Metals), and
(18.61 million Australian Dollars [US$14.63 million]
of which 88%
was Drug discovery and development).
Sales fell dramatically in 2017:
During the year ended December of 2017, sales at
Tempo Australia Limited were A$19.63 million (US$15.44 million).
decrease of 75.9%
versus 2016, when the company's sales were A$81.37 million.